Loading
Latest filing published 21 Jan 2009 for REGEN BIOLOGICS INC, €752k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Ivy Healthcare Capital II L P appears in our data through filings on Regen Biologics Inc shares, published by SEC (Form 4). Between 29 November 2008 and 16 January 2009, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 1 purchase, €752k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2009 to date brings 1 purchase and no sales.
The newest entry dates from 21 January 2009: an open-market purchase of €752k, in Regen Biologics Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations